Laparoscopically assisted uterine fibroid cryoablation.

Area of Science:

• Gynecology
• Minimally Invasive Surgery
• Oncology

Background:

• Uterine fibroids are common benign tumors affecting women of reproductive age.
• Symptomatic fibroids can lead to significant morbidity, including heavy bleeding and bulk symptoms.
• Current treatment options have limitations, necessitating the development of novel approaches.

Purpose of the Study:

• To develop and evaluate a safe and effective cryoablation technique for treating uterine fibroids.
• To assess the efficacy of cryoablation in reducing fibroid volume and improving patient-reported outcomes.

Main Methods:

• A multicenter pilot case series utilizing laparoscopically assisted placement of 17-gauge cryoablation needles.
• Patient satisfaction assessed using the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire.
• Procedural efficacy evaluated by fibroid shrinkage and symptom assessment at 3, 6, and 12 months post-treatment.

Main Results:

• Significant median fibroid volume reduction of 43.3% at 6 months and 66.4% at 12 months.
• Substantial improvement in UFS-QOL scores (61.9% at 6 months, 66.7% at 12 months).
• Marked reduction in bleeding and fibroid bulk symptoms, with Symptom Severity Scores decreasing by 59% at 6 months and 66.7% at 12 months.

Conclusions:

• Uterine fibroid cryoablation is a safe and effective minimally invasive treatment option.
• The technique demonstrates significant efficacy in fibroid volume reduction and symptom improvement.
• Cryoablation presents a promising alternative for managing symptomatic uterine fibroids.